,dataset_name,cell_type,cell_type_ontology_id,donor_id,sex,race,development_stage,count,percentage
0,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",T cell,CL:0000084,KR_SGI_H158,female,Korean,30-year-old human stage,28,2.066420664206642
1,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",erythrocyte,CL:0000232,KR_SGI_H158,female,Korean,30-year-old human stage,2,0.14760147601476015
2,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",platelet,CL:0000233,KR_SGI_H158,female,Korean,30-year-old human stage,88,6.494464944649446
3,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",B cell,CL:0000236,KR_SGI_H158,female,Korean,30-year-old human stage,23,1.6974169741697416
4,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",monocyte,CL:0000576,KR_SGI_H158,female,Korean,30-year-old human stage,21,1.5498154981549817
5,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",natural killer cell,CL:0000623,KR_SGI_H158,female,Korean,30-year-old human stage,24,1.7712177121771218
6,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta T cell",CL:0000624,KR_SGI_H158,female,Korean,30-year-old human stage,12,0.8856088560885609
7,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mature B cell,CL:0000785,KR_SGI_H158,female,Korean,30-year-old human stage,6,0.44280442804428044
8,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",memory B cell,CL:0000787,KR_SGI_H158,female,Korean,30-year-old human stage,104,7.675276752767528
9,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",naive B cell,CL:0000788,KR_SGI_H158,female,Korean,30-year-old human stage,11,0.8118081180811807
10,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta cytotoxic T cell",CL:0000794,KR_SGI_H158,female,Korean,30-year-old human stage,37,2.730627306273063
11,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",gamma-delta T cell,CL:0000798,KR_SGI_H158,female,Korean,30-year-old human stage,8,0.5904059040590406
12,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",regulatory T cell,CL:0000815,KR_SGI_H158,female,Korean,30-year-old human stage,13,0.959409594095941
13,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD4-positive, alpha-beta T cell",CL:0000895,KR_SGI_H158,female,Korean,30-year-old human stage,83,6.125461254612547
14,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD8-positive, alpha-beta T cell",CL:0000900,KR_SGI_H158,female,Korean,30-year-old human stage,140,10.33210332103321
15,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","central memory CD4-positive, alpha-beta T cell",CL:0000904,KR_SGI_H158,female,Korean,30-year-old human stage,117,8.634686346863468
16,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","effector memory CD4-positive, alpha-beta T cell",CL:0000905,KR_SGI_H158,female,Korean,30-year-old human stage,14,1.033210332103321
17,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta memory T cell",CL:0000909,KR_SGI_H158,female,Korean,30-year-old human stage,40,2.952029520295203
18,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta cytotoxic T cell",CL:0000934,KR_SGI_H158,female,Korean,30-year-old human stage,9,0.6642066420664207
19,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-negative, CD56-bright natural killer cell, human",CL:0000938,KR_SGI_H158,female,Korean,30-year-old human stage,10,0.7380073800738007
20,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-positive, CD56-dim natural killer cell, human",CL:0000939,KR_SGI_H158,female,Korean,30-year-old human stage,326,24.059040590405903
21,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mucosal invariant T cell,CL:0000940,KR_SGI_H158,female,Korean,30-year-old human stage,21,1.5498154981549817
22,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD14-positive monocyte,CL:0001054,KR_SGI_H158,female,Korean,30-year-old human stage,167,12.324723247232471
23,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",innate lymphoid cell,CL:0001065,KR_SGI_H158,female,Korean,30-year-old human stage,1,0.07380073800738007
24,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD141-positive myeloid dendritic cell,CL:0002394,KR_SGI_H158,female,Korean,30-year-old human stage,1,0.07380073800738007
25,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD14-low, CD16-positive monocyte",CL:0002396,KR_SGI_H158,female,Korean,30-year-old human stage,33,2.4354243542435423
26,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD1c-positive myeloid dendritic cell,CL:0002399,KR_SGI_H158,female,Korean,30-year-old human stage,16,1.1808118081180812
